title: Results of a diet/exercise feasibility trial to prevent adverse body composition change in breast cancer patients on adjuvant chemotherapy.
abstract: OBJECTIVE
  Patients with breast cancer on adjuvant chemotherapy can experience weight gain and concurrent losses in muscle mass. Exercise interventions can prevent these changes, but time and travel pose barriers to participation. The Survivor Training for Enhancing Total Health (STRENGTH) trial assessed the feasibility and impact of 2 home-based interventions.
  
  
  METHODS
  Ninety premenopausal patients with breast cancer on adjuvant chemotherapy were randomized to a calcium-rich diet (CA) intervention (attention control) or to 2 experimental arms: a CA + exercise (EX) arm or a CA + EX and high fruit and vegetable, low-fat diet (FVLF) arm. Exercise arms included aerobic and strength-training exercises. Body composition, weight status, waist circumference, dietary intake, physical activity, quality of life, anxiety, depression, serum lipids, sex hormone binding globulin, insulin, proinsulin, C-reactive protein, interleukin-1B, and tumor-necrosis factor receptor-II were measured at baseline and at 6-month follow-up.
  
  
  RESULTS
  Accrual targets were achieved and modest attrition was observed (8.8%). Self-reports suggest increased calcium intakes in all arms, and higher fruit and vegetable and lower fat intake in the CA + EX + FVLF arm; no differences in physical activity were observed. While measures of adiposity were generally lower in the CA + EX + FVLF arm, the only significant difference was in percentage of body fat (arms and legs); change in scores (mean +/- standard deviation) were +0.7% +/- 2.3% (CA); +1.2% +/- 2.7% (CA + EX); and +0.1% +/- 2% (CA + EX + FVLF; P = .047). Lean body mass was largely preserved, even in the control arm (net gain of 452 g +/- 2395 g). No differences were observed in other endpoints.
  
  
  CONCLUSIONS
  Diet and exercise interventions can prevent weight gain and adverse body composition changes, but more research is needed to determine optimally effective interventions that can be implemented during active treatment and that promote adherence.
authors.affiliation: Department of Behavioral Sciences, University of Texas, M. D. Anderson Cancer Center, Houston, TX 77030, USA. wdemarkw@mdanderson.org
authors.forename: Wendy
authors.initials: W
authors.lastname: Demark-Wahnefried
authors.forename: L Douglas
authors.initials: LD
authors.lastname: Case
authors.forename: Kimberly
authors.initials: K
authors.lastname: Blackwell
authors.forename: P Kelly
authors.initials: PK
authors.lastname: Marcom
authors.forename: William
authors.initials: W
authors.lastname: Kraus
authors.forename: Noreen
authors.initials: N
authors.lastname: Aziz
authors.forename: Denise Clutter
authors.initials: DC
authors.lastname: Snyder
authors.forename: Jeffrey K
authors.initials: JK
authors.lastname: Giguere
authors.forename: Edward
authors.initials: E
authors.lastname: Shaw
mesh_terms: D000328:Adult; D001823:Body Composition / Q000187:drug effects*; D001943:Breast Neoplasms / Q000188:drug therapy*; D002118:Calcium; D017024:Chemotherapy, Adjuvant / Q000009:adverse effects*; D004032:Diet; D018752:Diet, Fat-Restricted; D015444:Exercise; D005240:Feasibility Studies; D005260:Female; D006801:Humans; D008875:Middle Aged; D017697:Premenopause; D015430:Weight Gain / Q000187:drug effects
chemical_list: D002118:Calcium